Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model

<p>Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Shih-Shih Chen (15314296) (author)
Eará dahkkit:	Jacqueline C. Barrientos (15314299) (author), Gerardo Ferrer (15314302) (author), Morgan King-Richards (15314305) (author), Yu-Ju Chen (15314308) (author), Priyadarshini Ravichandran (15314311) (author), Michael Ibrahim (15314314) (author), Yasmine Kieso (15314317) (author), Sheila Waters (15314320) (author), Jeffery L. Kutok (15314323) (author), Marisa Peluso (15314326) (author), Sujata Sharma (15314329) (author), David T. Weaver (15314332) (author), Jonathan A. Pachter (15027774) (author), Kanti R. Rai (15314335) (author), Nicholas Chiorazzi (15314338) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Tumor Biology Therapeutic Research and Development Hematological Cancers Leukemias Small Molecule Agents Kinase inhibitors Tumor Microenvironment Immune cells and the microenvironment
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid